Intracranial Neoplasms and Paraneoplastic Disorders, Ependymoma
Adams & Victors Principles of Neurology, Chp 31, pg 655, Ropper, A.H.,et al, 2014
Primary Leptomeningeal Lymphoma
Neurol 81:1690-1696, Taylor, J.W.,et al, 2013
Long-Term Survival with Favorable Cognitive Outcome After Chemotherapy in Primary Central Nervous System Lymphoma
Ann Neurol 67:182-189, Juergens,A.,et al, 2010
Ventriculoperitoneal Shunt in Patients with Leptomeningeal Metastasis
Neurol 64:1625-1627, Omuro,A.M.P.,et al, 2005
Acute Methotrexate Neurotoxicity: Findings on Diffusion-Weighted Imaging and Correlation with Clinical Outcome
AJNR 25:1688-1695, Rollins,N.,et al, 2004
Central Nervous System Relapse in Non-Hodgkin Lymphoma
Arch Neurol 54:854-859, Bollen,E.L.E.M.,et al, 1997
Prognostic Significance of Coexistent Bulky Metastatic CNS Dis in Pts with Leptomeningeal Metastases
Arch Neurol 54:1364-1368, Chamberlain,M.C.&Kormanik,P.A., 1997
Chronic Lymphocytic Leukemia and the Central Nervous System:A clinical and Pathological Study
Neurol 46:19-25, Cramer,S.C.,et al, 1996
Leptomeningeal Carcinomatosis:Presenting Features and Prognostic Factors
Arch Neurol 53:626-632, Balm,M.&Hammack,J., 1996
Focal Tectal Tumors:Management and Prognosis
Neurol 44:953-956, Squires,L.A.,et al, 1994
Clinical Outcome in Aggressively Treated Meningeal Gliomatosis
Neurol 42:252-254, Grant,R.,et al, 1992
Cholesterol-Lowering Agent Myopathy (CLAM)
Neurol 41:1159-1160, London,S.F.,et al, 1991
Primary Meningeal B Lymphoma Presenting as a Subacute Ascending Polyradiculoneuropathy
JNNP 54:610-613, Julien,J.,et al, 1991
Congenital Brain Tumors:A Review of 45 Cases
AJR 155:587-593, Buetow,P.C.,et al, 1990
Neonatal Brain Tumors:CT & MR Findings
J Comput Assist Tomogr 12:10-20, Radkowski,M.A.,et al, 1988
Inflammatory Myopathies
NEJM 394:1925-1938, AllenBach,Y. & Benveniste,O., 2026
Clinical Presentation, Investigation Findings, and Outcomes of IgG4-Related Pachymeningitis,A Systematic Review
JAMA Neurol 82:193-199, Terrim,S.,et al, 2025
Clinicopathologic Features, Pathogenesis, and Treatment of Monoclonal Gammopathy-Associated Myopathies
Neurol 105:213101, Soontrapa,P.,et al, 2025
Neuroimaging Findings in Children and Young Adults with Neurotoxicity after CAR T-Cell Therapy for B-Cell Malignancies
Neurol 105:e214086, McGuire,J.L.,et al, 2025
Acromegaly
NEJM 393:1926-1939, Giustina,A. & Colao,A.,, 2025
A Randomized Trial of Shunting for Idiopathic Normal-Pressure Hydrocephalus
NEJM 393:2198-2209, 2264, Luciano,M.G.,et al, 2025
Cavernous Maliformations of the Central Nervous System
NEJM 390:1022-1028, Smith,E.R., 2024
Uncommon Causes of Nontraumatic Intracerebral Hemorrhage
Stroke 55:1416-1427, Tartarin,H.,et al, 2024
Paraneoplastic Calmodulin Kinase-Like Vesicle-Associated Protein (CAMKV) Autoimmune Encephalitis
Ann Neurol 96:21-33, Gilligan,M.,et al, 2024
Clinical Presentation, Management, and Outcome in Neurolymphomatosis, A Systematic Review
Neurol 103:e209698, Kaulen.L.D.,et al, 2024
Epilepsy in Patients with Primary CNS Lymphoma, Prevalence, Risk Factors, and Prognostic Significance
Neurol 103:e209748, Aboubakr,O.,et al, 2024
Reversible Cerebral Atrophy and Substantia Nigra Changes after Vitamin B12 Treatment in Infantile Tremor Syndrome
Neurol 103:e210076, Singh,R.,et al, 2024
Primary Central Nervous System Hodgkins Lymphoma - A Case Report and Review of Literature
J Neurosci Rural Prac 16:109-114, Thrinadh,B.,et al, 2024
Neonatal Seizures
NEJM 388:1692-1700, Ropper.A.H., 2023
Posterior Reversible Encephalopathy Syndrome
NEJM 388:2171-2178, Geocadin,R.G., 2023
Management and Long-term Outcomes of Adults With Medulloblastoma, A Single-Center Experience
Neurol 101:e1256-e1271, Neth,B.J.,et al, 2023
Glial Fibrillary Acidic Protein Autoimmunity
Neurol 98:e653-e668, Gravier-Dumonceau, A.,et al, 2022
Brain Tumors in Children
NEJM 386:1922-1931, Cohen, A.R., 2022
Rituximab Therapy in the Treatment of Juvenile Myasthenia Gravis
Neurol 98:e2368-e2376, Molimard, A.,et al, 2022
Neuromyelitis Optica Spectrum Disorder
NEJM 387:631-639, Wingerchuk, D.M. & Lucchinetti, C.F., 2022
A 65-Year-Old Woman with Cancer History and Wrist Drop
Neurol 99:570-576, Merrill, R.,et al, 2022
Spontaneous Intracerebral Hemorrhage
NEJM 387:1589-1596, Sheth, K.N., 2022
Infantile and Childhood Hydrocephalus
NEJM 387:2067-2073, Whitehead,W.E.&Weiner,J.L., 2022
Investigating Outcomes Post-Endovascular Thrombectomy in Acute Stroke Patients with Cancer
Neurol 99:e2583-e2592, Shapiro,S.D.,et al, 2022
Urothelial Carcinoma of the Bladder with Primary Metastasis to the Brain:A Case Report and Literature Review
Cureus doi:10.7759/cureus.27587, Sankhyan,M.,et al, 2022
The Phenotypic Continuum of ATP1A3-Related Disorders
Neurol 99:e1511-e1526, Vezyroglou,A., et al, 2022
Paraneoplastic Myeloneuropathies
Neurol 96:e632-e639, Shah, S.,et al, 2021
Immediate and Long-Term Outcomes of Reperfusion Therapy in Patients with Cancer
Stroke 52:2026-2034, Yoo, J.,et al, 2021
Encephalitis Induced by Immune Checkpoint Inhibitors
JAMA Neurol 78:864-873, Velasco, R.,et al, 2021
Chronic Meningitis
NEJM 385:930-936, Aksamit, A.J., 2021
Clinical Outcomes in Atrial Fibrillation Patients with a History of Cancer Treated with Non-Vitamin K Antagonist Oral Anticoagulants
Stroke 52:3132-3141, Chan, Y.H.,et al, 2021
Autoimmune Encephalitis Related to Cancer Treatment with Immune Checkpoint Inhibitors
Neurol 97:e191-e202, Nersesjan, V.,et al, 2021
Long-Term Follow-Up, Quality of Life, and Survival of Patients with Lambert-Eaton Myasthenic Syndrome
Neurol 94:e511-e520, Lipka, A.F.,et al, 2020
Management and Outcome of Primary CNS Lymphoma in the Modern Era
Neurol 94:e1027-e1039, Houillier, C., et al, 2020